Foundations of the Diagnosis and Management of Low-Grade Gliomas
- 1 October 2022
- journal article
- research article
- Published by Elsevier BV in World Neurosurgery
- Vol. 166, 306-312
- https://doi.org/10.1016/j.wneu.2022.06.068
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHOActa Neuropathologica, 2015
- Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade gliomaNeuro-Oncology, 2014
- Low-Grade GliomasThe Oncologist, 2014
- Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation ofIDHJournal of Clinical Oncology, 2014
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402Journal of Clinical Oncology, 2013
- Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade GliomasJAMA, 2012
- EXTENT OF SURGICAL RESECTION IS INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITH HEMISPHERIC INFILTRATING LOW-GRADE GLIOMASNeurosurgery, 2008
- Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric GliomasJournal of Clinical Oncology, 2008
- Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trialThe Lancet, 2005
- Glioma Classification: A Molecular ReappraisalThe American Journal of Pathology, 2001